“Establish implementation and coordination headquarters and resources: Preferably by leveraging the capacity of an existing forum (Rx&D and HealthCareCAN are recommending alignment with the CIHR Strategy for Patient Oriented Research (SPOR) if possible); establish an implementation committee and resources that would oversee and enable implementation of this action plan and that could coordinate, link and leverage, different activity types and inter-provincial clinical trial improvement activities.”
GOVERNMENT ANNOUNCEMENT ON CREATION OF THE CCTCC
On April 24, 2014, The Government of Canada announced the creation of the Canadian Clinical Trials Coordinating Centre (CCTCC) – a collaborative effort of the Canadian Institutes of Health Research (CIHR), Canada’s Research-Based Pharmaceutical Companies (Rx&D), and the merged organizations of the Association of Canadian Academic Healthcare Organizations and the Canadian Healthcare Association (ACAHO/CHA). The CCTCC is based at 116 Albert Street, Ottawa, Ontario.
MEET THE PEOPLE BEHIND THE CCTCC
Meet Elena Aminkova, the CCTCC Interim Director of Project Facilitation and Leyla Di Cori, the Communications and Strategy Coordinator.
The CCTCC is governed by the Executive Committee, made up of senior representatives from each of the three funding partners (CIHR, Rx&D and HealthCareCAN).
The CCTCC National Advisory Group is comprised of twelve members representing a wide cross section of the Canadian clinical trials landscape. They provide advice and expertise to the CCTCC Executive Committee, ensuring the goals of the organization are met. The members also serve as ambassadors for the CCTCC and its mission. Access the Press Release : Creation of CCTCC National Advisory Group.